Amedisys (AMED) PT Lifted to $28 at Piper Jaffray; 'Hold' Maintained

March 5, 2015 7:20 AM

Piper Jaffray analyst Kevin Ellich bumped his price target on Amedisys (NASDAQ: AMED) to $28.00 (from $24.00) following in-line Q4 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found